Ribosome display and affinity maturation: from antibodies to single V-domains and steps towards cancer therapeutics

被引:68
作者
Irving, RA
Coia, G
Roberts, A
Nuttall, SD
Hudson, PJ
机构
[1] CSIRO, Parkville, Vic 3052, Australia
[2] CRC Diagnost Technol, Parkville, Vic 3052, Australia
关键词
antibody engineering; phage display; ribosome display; affinity maturation; V-domains; single chain Fvs;
D O I
10.1016/S0022-1759(00)00341-0
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
Protein affinity maturation using molecular evolution techniques to produce high-affinity binding proteins is an important step in the generation of reagents for cancer diagnosis and treatment. Currently, the most commonly used molecular evolution processes involve mutation of a single gene into complex gene repertoires followed by selection from a display library. Fd-bacteriophage are the most popular display vectors, but are Limited in their capacity for library presentation, speed of processing and mutation frequency. Recently, the potential of ribosome display for directed molecular evolution was recognised and developed into a rapid and simple affinity selection strategy using ribosome complexes to display antibody fragments (scFv). Ribosome display and selection has the potential to generate and display large Libraries more representative of the theoretical optima for naive repertoires (10(14)). Even more important is the application of ribosome display for the affinity maturation of individual proteins by rapid mutation and selection cycles. These display strategies can apply to other members of the immunoglobulin superfamily; for example single V-domains which have an important application in providing specific targeting to either novel or refractory cancer markers. We discuss the application of ribosome display and selection in conjunction with variable domain (CTLA-4) libraries as the first step towards this objective and review affinity maturation strategies for in vitro ribosome display systems. (C) 2001 Elsevier Science BN: All rights reserved.
引用
收藏
页码:31 / 45
页数:15
相关论文
共 81 条
[1]  
Adams GP, 1998, CANCER RES, V58, P485
[2]   Stable heterodimers from remodeling the domain interface of a homodimer using a phage display library [J].
Atwell, S ;
Ridgway, JBB ;
Wells, JA ;
Carter, P .
JOURNAL OF MOLECULAR BIOLOGY, 1997, 270 (01) :26-35
[3]  
Baca M, 1997, J BIOL CHEM, V272, P10678
[4]   Placement of protein and RNA structures into a 5 Å-resolution map of the 50S ribosomal subunit [J].
Ban, N ;
Nissen, P ;
Hansen, J ;
Capel, M ;
Moore, PB ;
Steitz, TA .
NATURE, 1999, 400 (6747) :841-847
[5]   PROPORTION OF REVERTANT AND MUTANT PHAGE IN A GROWING POPULATION, AS A FUNCTION OF MUTATION AND GROWTH-RATE [J].
BATSCHELET, E ;
DOMINGO, E ;
WEISSMANN, C .
GENE, 1976, 1 (01) :27-32
[6]   Guided selection of a pan carcinoma specific antibody reveals similar binding characteristics yet structural divergence between the original murine antibody and its human equivalent [J].
Beiboer, SHW ;
Reurs, A ;
Roovers, RC ;
Arends, JW ;
Whitelegg, NR ;
Rees, AR ;
Hoogenboom, HR .
JOURNAL OF MOLECULAR BIOLOGY, 2000, 296 (03) :833-849
[7]   TRANSLATION RATES OF INDIVIDUAL CODONS ARE NOT CORRELATED WITH TRANSFER-RNA ABUNDANCES OR WITH FREQUENCIES OF UTILIZATION IN ESCHERICHIA-COLI [J].
BONEKAMP, F ;
DALBOGE, H ;
CHRISTENSEN, T ;
JENSEN, KF .
JOURNAL OF BACTERIOLOGY, 1989, 171 (11) :5812-5816
[8]  
Bradbury Andrew, 1999, Trends in Biotechnology, V17, P137, DOI 10.1016/S0167-7799(98)01289-X
[9]   Engineering antibodies for imaging and therapy [J].
Carter, P ;
Merchant, AM .
CURRENT OPINION IN BIOTECHNOLOGY, 1997, 8 (04) :449-454
[10]   Use of mutator cells as a means for increasing production levels of a recombinant antibody directed against Hepatitis B [J].
Coia, G ;
Ayres, A ;
Lilley, GG ;
Hudson, PJ ;
Irving, RA .
GENE, 1997, 201 (1-2) :203-209